Xenon Pharmaceuticals Inc. (XENE) Social Stream
Xenon Pharmaceuticals Inc (XENE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Xenon Pharmaceuticals Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 21 months, XENE's average price target has gone up $22.03.
XENE reports an average of 51.71% for its upside potential over the past 46 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
XENE Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
XENE's average broker recommendation rating improved by 0 over the prior 120 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of stocks in the small market cap category, Xenon Pharmaceuticals Inc's number of analysts covering the stock is greater than 443.3% of them.
- XENE has a greater average analyst price target than 425.34% of stocks in the small market cap category.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Xenon Pharmaceuticals Inc's variance in analysts' estimates is lower than 5.08% of them.
- In terms of how Xenon Pharmaceuticals Inc fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 107.79% of that group.
In the Pharmaceutical Products industry, XBIT, WVE, and VYNE are the three stocks most similar to Xenon Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.
Is XENE a Buy, Hold or Sell? See the POWR Ratings now!